Simplification to dual therapy (atazanavir / ritonavir plus lamivudine) versus standard triple therapy [atazanavir / ritonavir plus two nucleos (t) ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
FI: 5,071
Type: Article
Collaboration
Year: 2017
Writers
Perez-Molina, JA; Rubio, R; Rivero, A; Pasquau, J; Suarez-Lozano, I; Riera, M; Estebanez, M; Palacios, R; Sanz-Moreno, J; Troy, J; Marino, A; Antela, A; Navarro, J; Esteban, H; Moreno, S
Magazine
Title: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Quartile
- D1